Tarsier
@tarsierpharma.com
CHANGING LIVESBY SAVING SIGHT A Bio-Inspired Therapeutic PlatformThat Offers A Bright FutureFor Patients Suffering FromBlinding Ocular Diseases CHANGING LIVESBY SAVING SIGHT A Bio-Inspired Therapeutic Platform Offering A Bright Future For Patients Suffering From Blinding Ocular Diseases ABOUT US We are a late clinical-stage company dedicated to developing disruptive bio-inspired medical solutions for the treatment and […]
Tarsier's Company Logos
Tarsier's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#F6921E
Tree Poppy
246, 146, 30
32, 92, 54
0, 41, 88, 4
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#14171A
Woodsmoke
20, 23, 26
210, 13, 9
23, 12, 0, 90
About Tarsier
Tarsier® Pharma is a brand at the forefront of developing and commercializing groundbreaking therapeutic solutions for autoimmune and inflammatory ocular diseases. With a focus on better and safer treatments, Tarsier® combines innovation and technology to address the critical underlying mechanisms of ocular inflammation. Their flagship product, the Dazdotuftide (TRS) Platform Technology, is a bio-inspired immunomodulator designed to treat various ocular inflammatory conditions.
It is currently being developed as both eye drops and intravitreal injections. This versatile technology offers hope to millions of people suffering from ocular inflammatory diseases worldwide, including uveitic glaucoma, non-evaporative dry eye, diabetic macular edema (DME), and dry age-related macular degeneration (AMD). Led by a global team of experienced professionals and backed by strategic investors in ophthalmology, Tarsier® Pharma is committed to disrupting the treatment landscape for ocular inflammatory diseases.
With their cutting-edge immunomodulatory approach, they aim to improve the lives of patients and reduce the risks of vision loss and blindness associated with these conditions
Company type
Privately Held
Year founded
2016
Company size
2-10 employees
